VARDENAFIL SANDOZ 5 mg, film-coated tablet 4 tablets
Active ingredients: Vardenafil hydrochloride trihydrate, Vardenafil
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet4 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VARDENAFIL SANDOZ 5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 4 comprimé(s)
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 10 Jan 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67075622CIP73010880CIP133400930108802Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VARDÉNAFILcomprimé | 5 mg · un comprimé | FT |
| CHLORHYDRATE DE VARDÉNAFIL TRIHYDRATÉcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.